Non-continuous neuromodulation in awake, unrestrained felines increases bladder capacity

This study demonstrates that non-continuous neuromodulation, triggered by either dorsal root ganglia signals or bladder volume thresholds, effectively increases bladder capacity in awake, unrestrained felines to a degree comparable to continuous stimulation while significantly reducing total stimulation time.

The Gist

The Big Picture: A "Smart" Bladder Alarm System

Imagine your bladder is like a water balloon. When it gets full, it sends a signal to your brain saying, "Hey, I'm getting tight! Time to go to the bathroom!"

For people with Overactive Bladder (OAB), this signal is broken. The balloon feels like it's about to pop even when it's only half full. This causes a constant, urgent need to pee, even when there's very little urine inside.

Currently, doctors use a therapy called Neuromodulation. Think of this as a "pacemaker" for the bladder nerves. It sends electrical pulses to calm the nerves down, telling the bladder to relax and hold more urine.

The Problem with Current Therapy:
Most devices send these electrical pulses continuously (24/7), like a lightbulb that is always on.

• The Downside: This wastes battery life. Also, nerves can get used to a constant signal (like how you stop noticing the hum of a refrigerator), making the treatment less effective over time.

The Goal of This Study:
The researchers wanted to build a "Smart Lightbulb." Instead of being on all the time, they wanted the device to turn on only when the bladder actually needed it. They also wanted to see if they could "listen" to the nerves to know exactly when to turn the light on, without needing a catheter inside the bladder to measure pressure.

---

The Experiment: Training the "Cats"

To test this, the researchers used cats (felines). Why cats? Because their bladder and nerve systems are very similar to humans, and they are big enough to carry the equipment, unlike mice.

1. The Setup (The Backpack and the Wires)
The team performed surgery on seven cats. They implanted:

• Stimulators: Tiny electrodes placed on the nerves that control the bladder (the "pudendal" and "sacral" nerves).
• Microphones (Sensors): Tiny arrays placed on the Dorsal Root Ganglia (DRG). Think of the DRG as a relay station or a "switchboard" where sensory signals from the body enter the spinal cord. These sensors acted like microphones, listening to the electrical chatter of the bladder nerves.
• A Backpack: A small device on the cat's back held the wires and connectors, allowing the cat to walk around freely in a room.

2. The Three Modes of Operation
The researchers tested the cats in three different scenarios:

• Mode A (No Stimulation): Just let the bladder fill up naturally. This is the "control" to see how much the cat can hold normally.
• Mode B (Continuous Stimulation): The device sent electrical pulses constantly, like a lightbulb left on all day.
• Mode C (Non-Continuous / "Smart" Stimulation): This was the star of the show. The device listened to the "microphones" (DRG sensors).
  • The Logic: "If the bladder pressure starts rising too fast, or if the bladder is half full, THEN turn on the electrical pulses."
  • The Result: The device only turned on when necessary, then turned off when the bladder relaxed.

---

The Results: Did the "Smart" System Work?

1. Holding Capacity: The Same, But Smarter
The cats with the "Smart" system (Mode C) could hold just as much urine as the cats with the "Always On" system (Mode B).

• The Analogy: It's like having a security guard who stays awake 24/7 (Continuous) vs. a security guard who only wakes up when they hear a noise (Smart). Both kept the house safe, but the Smart guard got to sleep for half the day.
• The Win: The "Smart" system reduced the time the electricity was on by about 46%. This means the battery would last much longer, and the nerves wouldn't get "tired" of the signal.

2. Listening to the Nerves: The "Static" Problem
The researchers hoped to decode the bladder pressure directly from the nerve signals in real-time.

• The Challenge: When the cats were asleep (sedated), the "microphones" heard the bladder clearly. But when the cats were awake and walking around, the signals were full of static noise (like trying to listen to a radio station while driving through a tunnel).
• The Outcome: They managed to estimate the pressure well enough to trigger the stimulation in some cats, but it wasn't perfect yet. The movement of the cat and the backpack created too much interference.

3. Comfort
The cats didn't seem bothered by the stimulation. They continued to eat, play, and walk around. They didn't show signs of pain or anxiety, which is a huge plus for future human patients.

---

Why This Matters (The "So What?")

1. Better Battery Life: If this technology works in humans, the implantable device won't need battery replacements as often because it's not wasting energy.
2. Better Long-Term Results: By not blasting the nerves 24/7, the body is less likely to get used to the treatment and stop working.
3. Moving Away from Anesthesia: Most previous studies were done on animals under anesthesia (drugged sleep). This study proved it can work on awake, moving animals, which is a much better predictor of how it will work in real humans.

The Hurdles Ahead

The researchers admit it's not perfect yet.

• The Noise: They need better "noise-canceling headphones" for the sensors so they can hear the bladder clearly even when the patient is walking around.
• The Interface: The current sensors are a bit rigid. They might need to invent "flexible" sensors that hug the nerves better, like a soft glove instead of a hard glove.

Summary

This study is a major step forward. It proved that we can create a smart, on-demand bladder therapy that works just as well as the old "always-on" method but uses half the energy. While the "listening" part still needs some tuning to handle the noise of daily life, the concept of a bladder pacemaker that wakes up only when needed is now a very real possibility.

Technical Summary

1. Problem Statement

Overactive bladder (OAB) is a prevalent condition often treated with sacral neuromodulation (SNM). Standard clinical devices typically use Continuous Stimulation (CS). However, prolonged CS can lead to nerve habituation (reduced efficacy over time) and increased energy consumption. While Non-Continuous Stimulation (NCS) or closed-loop stimulation (CLS) triggered by bladder activity has shown promise in anesthetized models, two critical gaps remain:

1. Anesthesia Limitations: Most prior studies were conducted under anesthesia, which alters bladder and neural physiology, limiting clinical translation.
2. Awake Feasibility: It is unknown if NCS/CLS can effectively increase bladder capacity in awake, unrestrained animals, nor is it established if bladder pressure can be reliably decoded from neural signals in this state to trigger stimulation.

2. Methodology

Animal Model & Surgical Implantation:

• Subjects: Seven adult, male, neurologically intact felines (1.29 ± 0.19 years old).
• Implants:
  • Stimulation: Bipolar cuff electrodes placed on the pudendal nerve and sacral nerve (ipsilateral).
  • Recording: Microelectrode arrays (4x8 layout, IrOx shanks) inserted into the L7-S1 and L7-S2 Dorsal Root Ganglia (DRG) (equivalent to human S2-S3).
  • Bladder: Two catheters implanted in the bladder dome for saline infusion and pressure recording.
  • Interface: A 3D-printed "backpack" secured to the iliac crests housed connectors for the catheters and electrodes.
• Exclusion: One animal (Animal 7) was removed due to a catheter-related health issue; three animals (1-3) were used for procedure establishment; four animals (3-6) provided the primary experimental data.

Experimental Paradigm:

• Setting: Awake, unrestrained testing in a clear plexiglass chamber allowing free movement.
• Protocols: Fixed-sequence bladder fills were performed under three conditions:
  1. No Stimulation (NS): Baseline control.
  2. Continuous Stimulation (CS): Stimulation at 5 Hz, Motor Threshold (MT), 210 µs pulse width.
  3. Non-Continuous Stimulation (NCS):
     • CLS Mode (Animals 3 & 4): Stimulation triggered by real-time DRG signal decoding. Stimulation (15s) occurred when estimated bladder pressure increased by ≥5 cmH₂O in a 4s window.
     • Volume-Threshold Mode (Animals 5 & 6): Stimulation triggered when bladder volume reached 50% of the average NS capacity.

Data Processing:

• Decoding: Unsorted DRG spikes were detected via dual-threshold crossing. A Kalman filter decoder was trained on NS trials to estimate bladder pressure from neural firing rates.
• Metrics: Bladder capacity (infused/voided volume), bladder compliance, peak voiding pressure, and voiding efficiency.
• Statistical Analysis: One-way ANOVA with Tukey HSD and Bonferroni correction; correlation coefficients (R) for pressure decoding.

3. Key Contributions

• First Awake, Unrestrained CLS: This is the first study to demonstrate real-time closed-loop neuromodulation using neural recordings in an awake, medium-sized animal model (feline) moving freely.
• Validation of NCS Efficacy: Proved that NCS yields bladder capacity increases comparable to CS without the need for continuous power delivery.
• DRG Decoding in Awake State: Demonstrated the feasibility (albeit with variability) of estimating bladder pressure from DRG signals in awake animals, a critical step for implantable closed-loop systems.
• Physiological Insight: Showed that stimulation increases bladder compliance (detrusor inhibition) without altering peak voiding pressure or voiding efficiency, suggesting a mechanism of action that relaxes the bladder wall rather than obstructing outflow.

4. Key Results

Bladder Capacity:

• NCS vs. CS: NCS increased bladder capacity to 122 ± 31% of the NS control, which was statistically similar to CS (121 ± 33%).
• Stimulation Reduction: NCS reduced total stimulation time by an average of 46% compared to CS.
• Efficacy by Animal:
  • Animals 3, 4, and 6 showed significant capacity increases with NCS/CLS.
  • Animal 5 showed no significant effect (likely due to electrode failure or behavioral factors).
• Stimulation Location: No significant difference was found between stimulation at the pudendal vs. sacral nerve regarding efficacy.

Neural Decoding Performance:

• Correlation: In awake trials with functioning "bladder units" (neurons correlated to pressure), the median correlation between predicted and measured pressure was 0.46 (Animal 3) and 0.64 (Animal 4).
• Challenges: Decoding performance was highly variable. Noise from movement (backpack/cables) and the inconsistent presence of specific bladder units between sedated (training) and awake (testing) states degraded performance. Offline analysis of sorted units showed better correlations (0.52–0.55) than real-time unsorted decoding.

Physiological Effects:

• Compliance: Significant increases in bladder compliance were observed in Animals 3 and 4 during stimulation, indicating detrusor relaxation.
• Voiding: No significant changes were observed in peak bladder pressure or voiding efficiency, confirming that stimulation did not cause urinary retention or obstruction.
• Carry-over: No long-term carry-over effects (sustained capacity increase after stimulation ceased) were observed within the study timeframe.

5. Significance and Future Directions

• Clinical Translation: The study validates that NCS is a viable alternative to CS, offering similar therapeutic benefits (increased capacity) with significantly lower energy consumption and reduced risk of habituation. This supports the development of next-generation implantable devices that stimulate only when necessary.
• Closed-Loop Potential: While real-time decoding in awake animals is feasible, the current reliance on unsorted spikes and movement artifacts highlights the need for:
  • Improved Electrodes: Flexible arrays conforming to the curved DRG surface to reduce micromotion.
  • Advanced Algorithms: Adaptive decoders that can handle non-linear relationships and noise in awake states.
  • Model Refinement: Future studies should investigate whether non-voiding contractions (common in OAB models) occur in awake healthy animals to refine trigger algorithms.
• Conclusion: This work bridges the gap between pre-clinical anesthetized studies and clinical reality, demonstrating that awake, unrestrained neuromodulation can effectively manage bladder dysfunction.